BAX Stock Price, Chart, Stats & News

Baxter International Inc.
Save
BAX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 30.05% |
Operating margin | -2.74% |
Pretax margin | -4.49% |
Net margin | -8.51% |
Effective tax rate | -78.22% |
ROA | -4.77% |
ROE | -13.78% |
D/E | 1.60x |
Interest coverage ratio | -1.06x |
BAX valuation
P/E | – |
P/S | 0.73x |
P/B | 1.34x |
P/CF | 9.71x |
P/FCF | 25.44x |
P/OCF | 9.71x |
PEG | 0.05x |
EV multiple | 0.53x |
About
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution.
Similar securities
Based on sector and market capitalization
Report issue











